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Figure	1.	Clearance	of	Streptococcus	pneumoniae	from	plasma	is	enhanced	in	mice	heterozygous	for	the	gene	encoding	factor	H	(FH).	
A–C,	Wild-type	(CA	+/+;	n	=	10),	heterozygous	(CA	+/−;	n	=	10),	and	homozygous	(CA	−/−	n	=	10)	FH-deﬁcient	C57BL/6	mice	were	
infected	with	1	×	107	 colony-forming	units	 (CFU)	of	S.	 pneumoniae	 (TIGR4)	 and	 sacriﬁced	19	hours	 later.	 #Four	of	 the	10	CA	−/−	
animals	 were	 sacriﬁced	 before	 this	 because	 the	 predeﬁned	 humane	 end	 point	 was	 reached.	 Nineteen	 hours	 aZer	 infec[on,	 the	
number	of	CFU	per	milliliter	was	determined	in	blood,	and	levels	of	proinﬂammatory	cytokines	interleukin	6	(IL-6)	and	macrophage	
inﬂammatory	 protein	 2	 (MIP-2)	 were	 measured	 in	 serum.	 Each	 point	 represents	 1	 mouse.	 Cytokine	 values	 were	 analyzed	 aZer	
logarithmic	 transforma[on;	 horizontal	 line	 represents	 the	 median.	 Comparisons	 between	 groups	 were	 performed	 using	 the	
nonparametric	Mann–Whitney	test	with	the	Bonferroni	correc[on.	*P	<	.05,	**P	<	.01,	and	***P	<	.001.		
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Figure	2.	Administra[on	of	human	factor	H	(FH)	to	wild-type	mice	impaired	plasma	clearance	of	Streptococcus	pneumoniae.	A–C,	
Wild-type	C57BL/6	mice	were	intravenously	infected	with	1	×	107	colony-forming	units	of	S.	pneumoniae	(TIGR4)	and	injected	with	
puriﬁed	human	FH	(n	=	10)	or	phosphate-buﬀered	saline	(n	=	10)	and	sacriﬁced	21	hour	later.	Twenty-one	hours	aZer	infec[on,	the	
number	of	colony-forming	units	(CFU)	per	milliliter	was	determined	in	blood,	and	levels	of	the	proinﬂammatory	cytokines	IL-6	and	
MIP-2	were	measured	in	serum.	Each	point	represents	one	mouse;	cytokine	values	were	analyzed	aZer	logarithmic	transforma[on;	
horizontal	lines	represents	the	median.	Comparisons	between	groups	were	performed	using	the	nonparametric	Mann-Whitney	test	
with	the	Bonferroni	correc[on.	*P	<	.05,	**P	<	.01,	and	***P	<	.001.	
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Figure	3.	Pneumococcal	C3	opsoniza[on	is	enhanced	in	mice	heterozygous	for	the	gene	encoding	factor	H	(FH).	C3	deposi[on	on	the	
surface	of	Streptococcus	pneumoniae	strain	TIGR4	in	pooled	mouse	serum	derived	from	CA	+/+,	CA	+/−,	or	CA	−/−	mice.	A	total	of	5	
×	 107	 colony-forming	 units/mL	 S.	 pneumoniae	 TIGR4	 were	 incubated	 in	 20%	mice	 serum	 in	 veronal	 buﬀer	 containing	Mg2+	 and	
ethylene	 glycol	 tetraace[c	 acid.	 AZer	 90	 minutes	 of	 incuba[on	 at	 37°C,	 pneumococcal	 C3	 deposi[on	 was	 measured	 by	 ﬂow	
cytometry.	 A,	 A	 representa[ve	 example	 of	 a	 ﬂow	 cytometry	 histogram	 for	 bacteria	 incubated	 in	 wild-type	 (FH+/+;	 white	 peak),	
heterozygous	 (FH+/−;	 gray	 peak),	 and	 homozygous	 (FH−/−;	 black	 peak)	 FH-deﬁcient	 pooled	 mouse	 serum.	 B,	 Intensity	 of	 C3	
deposi[on	on	bacteria.	C,	Propor[on	of	C3-posi[ve	bacteria.	For	panels	B	and	C,	each	bar	represents	the	mean	±	standard	error	of	
the	mean	for	results	obtained	from	5	separate	experiments.	Comparisons	between	groups	were	performed	using	a	paired	Student	t	
test.*P	<	.05,	**P	<	.01,	***P	<	.001.	Abbrevia[on:	NS,	not	signiﬁcant.		
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Figure	4.	Pneumococcal	C3	opsoniza[on	in	wild-type	mice	serum	is	 impaired	by	excess	human	factor	H	(FH).	C3	deposi[on	on	the	
surface	of	S.	pneumoniae	strain	TIGR4	 in	pooled	wild-type	mouse	serum	with	addi[onal	human	FH.	S.	pneumoniae	TIGR4,	5	×	107	
colony-forming	units/mL,	were	incubated	in	20%	mice	serum	in	Veronal	buﬀer	containing	Mg2+	and	ethylene	glycol	tetraace[c	acid.	
AZer	90	minutes	of	incuba[on	at	37°C,	pneumococcal	C3	deposi[on	was	measured	by	ﬂow	cytometry.	A,	A	representa[ve	example	
of	a	ﬂow	cytometry	histogram	for	bacteria	incubated	in	wild-type	(CA+/+;	white	peak),	wild-type	with	exogenous	human	FH	(CA	+/+	
[+FH];	gray	peak),	and	heat-inac[vated	mouse	serum	(HI)	as	a	nega[ve	control	(black	peak).	B,	Intensity	of	C3	deposi[on	on	bacteria.	
C,	Propor[on	of	C3-posi[ve	bacteria.	The	bars	 in	panels	B	and	C	 represent	 the	mean	±	standard	error	of	 the	mean	of	2	 separate	
experiments	in	duplicate.	Comparisons	between	groups	were	performed	using	a	paired	Student	t	test.	*P	<	.05,**P	<	.01,	***P	<	.
001.	Abbrevia[on:	NS,	not	signiﬁcant.	
	
	
Van	der	Maten	et	al	
	
Complement	Factor	H	Serum	Levels	Determine	Resistance	to	Pneumococcal	Invasive	Disease	
	
J	Infect	Dis.	2016	Jun	1;213(11):1820-7.	doi:	10.1093/infdis/jiw029.	Epub	2016	Jan	21	
Figure	5.	Alterna[ve	pathway	modula[on	by	human	factor	H	(FH)	levels	determines	pneumococcal	C3	opsoniza[on.	C3	deposi[on	on	
the	surface	of	Streptococcus	pneumoniae	strain	TIGR4	in	human	FH–depleted	serum	recons[tuted	with	various	FH	concentra[ons.	S.	
pneumoniae	TIGR4,	5	×	107	colony-forming	units/mL,	were	 incubated	 in	10%	human	serum	 in	Veronal	buﬀer	containing	Mg2+	and	
ethylene	 glycol	 tetraace[c	 acid.	 AZer	 30	 minutes	 of	 incuba[on	 at	 37°C,	 pneumococcal	 C3	 deposi[on	 was	 measured	 by	 ﬂow	
cytometry.	A,	A	representa[ve	example	of	a	ﬂow	cytometry	histogram	for	bacteria	 incubated	 in	FH-depleted	serum	recons[tuted	
with	the	physiological	FH	concentra[on	of	500	μg/mL	FH	(light	gray),	or	0	μg/mL	(black),	300	μg/mL	(white),	or	1000	μg/mL	(dark	
gray)	FH.	B,	Propor[on	of	C3-posi[ve	cells.	Each	bar	represents	the	mean	±	standard	error	of	the	mean	of	results	obtained	from	4	
separate	experiments.	Comparison	of	various	FH	concentra[ons	to	the	physiological	FH	concentra[on	of	500	μg/mL	(gray	bar)	were	
performed	by	using	a	repeated	measures	analysis	of	variance	with	the	Bonferroni	correc[on.	*P	<	.05,	**P	<	.01,	and	***P	<	.001.	
Abbrevia[on:	NS,	not	signiﬁcant		
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Figure	6.	Alterna[ve	pathway	modula[on	by	human	factor	H	(FH)	determines	pneumococcal	killing	in	blood.	Pneumococcal	killing	in	
human	blood	containing	FH-depleted	serum	recons[tuted	with	various	FH	concentra[ons.	Streptococcus	pneumoniae	TIGR4,	1	×	106	
colony-forming	 units/mL,	 were	 incubated	 in	 healthy	 donor	 blood	 in	 which	 plasma	 was	 replaced	 by	 human	 FH–depleted	 serum	
recons[tuted	with	various	FH	concentra[ons	or	with	heat-inac[vated	(HI)	serum	as	a	control.	The	number	of	colony-forming	units	
were	 determined	 by	 pla[ng	 serial	 dilu[ons	 before	 incuba[on	 and	 240	minutes	 aZer	 incuba[on	 at	 37°C,	 and	 the	 percentage	 of	
surviving	bacteria	was	calculated.	Each	dot	represents	1	blood	donor.	Comparisons	of	various	FH	concentra[ons	to	the	physiological	
FH	concentra[on	of	500	μg/mL	 (white	dots)	were	performed	using	a	 repeated	measures	analysis	of	 variance	with	 the	Bonferroni	
correc[on.	*P	<	.05	was	considered	signiﬁcant.	**P	<	.01	and	
***P	<	.001.	
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